168 related articles for article (PubMed ID: 2229139)
1. Value of bone scanning in the follow-up of breast cancer patients. A study of 1000 cases.
Schünemann H; Langecker PJ; Ellgas W; Leonhardt A; Merkl H
J Cancer Res Clin Oncol; 1990; 116(5):486-91. PubMed ID: 2229139
[TBL] [Abstract][Full Text] [Related]
2. Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy.
Perez DJ; Powles TJ; Milan J; Gazet JC; Ford HT; McCready VR; MacDonald JS; Coombes RC
Lancet; 1983 Sep; 2(8350):613-6. PubMed ID: 6136757
[TBL] [Abstract][Full Text] [Related]
3. [The value of skeletal scintigraphy in the aftercare of breast carcinoma. A prospective study of 750 cases].
Schünemann H; Jourdain M
Dtsch Med Wochenschr; 1989 Jan; 114(1):3-8. PubMed ID: 2535982
[TBL] [Abstract][Full Text] [Related]
4. [Status of skeletal scintigraphy, lung roentgen image and liver sonography in the follow-up of breast cancer].
Schünemann H
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):379-84. PubMed ID: 2661306
[TBL] [Abstract][Full Text] [Related]
5. Baseline staging tests in primary breast cancer: a practice guideline.
Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
[TBL] [Abstract][Full Text] [Related]
6. Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.
Yeh KA; Fortunato L; Ridge JA; Hoffman JP; Eisenberg BL; Sigurdson ER
Ann Surg Oncol; 1995 Jul; 2(4):319-24. PubMed ID: 7552621
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams.
Ohmori K; Matsui H; Yasuda T; Kanamori M; Yudoh K; Seto H; Tsuji H
Jpn J Clin Oncol; 1997 Aug; 27(4):263-7. PubMed ID: 9379516
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic imaging of bone metastases].
Scutellari PN; Addonisio G; Righi R; Giganti M
Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
[TBL] [Abstract][Full Text] [Related]
9. 'For' or 'against' bone scintigraphy of patients with breast cancer.
Derimanov SG
Nucl Med Commun; 1987 Feb; 8(2):79-86. PubMed ID: 3587793
[TBL] [Abstract][Full Text] [Related]
10. [Value of skeletal scintigraphy in the therapy of breast cancer].
Köhler AH; Weidig W
Zentralbl Chir; 1982; 107(22):1433-9. PubMed ID: 7164627
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance tomography of the bone marrow in cancer patients with a solitary area of increased uptake in the bone scintigram].
Smolarz K; Jungehülsing M; Krug B; Linden A; Göhring UJ; Schicha H
Nuklearmedizin; 1990 Dec; 29(6):269-73. PubMed ID: 2075088
[TBL] [Abstract][Full Text] [Related]
12. Radionuclide bone scan in initial staging of breast cancer.
Boughattas S; Hassine H; Chatti K; Essabbah H
Tunis Med; 2003 Mar; 81(3):156-61. PubMed ID: 12793064
[TBL] [Abstract][Full Text] [Related]
13. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
Buscombe JR; Holloway B; Roche N; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of first indicators of breast cancer recurrence.
Pivot X; Asmar L; Hortobagyi GN; Theriault R; Pastorini F; Buzdar A
Oncology; 2000 Apr; 58(3):185-90. PubMed ID: 10765118
[TBL] [Abstract][Full Text] [Related]
15. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.
Michel F; Solèr M; Imhof E; Perruchoud AP
Thorax; 1991 Jul; 46(7):469-73. PubMed ID: 1652164
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic bone disease. Strategies for imaging].
Scutellari PN; Antinolfi G; Galeotti R; Giganti M
Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
[TBL] [Abstract][Full Text] [Related]
18. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
[TBL] [Abstract][Full Text] [Related]
19. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
Creutzig H
Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
[TBL] [Abstract][Full Text] [Related]
20. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
